BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260609
DTEND;VALUE=DATE:20260612
DTSTAMP:20260514T232719
CREATED:20260224T133550Z
LAST-MODIFIED:20260224T133750Z
UID:42982-1780963200-1781222399@www.pharmajournalist.com
SUMMARY:5th World ADC Summit South Korea
DESCRIPTION:The 5th World ADC Summit South Korea (previously World ADC Asia)\, taking place 9–11 June 2026 in Seoul\, stands as the Asia’s premier meeting dedicated to accelerating next‑generation antibody–drug conjugate (ADC) development. \nAs South Korea rapidly transitions from a biosimilar‑focused market to a global innovator in precision oncology\, ADCs have emerged as a centrepiece of this shift. The summit responds to this momentum by offering a comprehensive\, end‑to‑end forum covering discovery\, preclinical development\, clinical translation\, and CMC innovation. With more than 300 industry experts expected to attend\, the event brings together leading organizations to exchange insights on novel and dual‑payloads\, bispecific ADCs\, and strategies to overcome Topo‑1 resistance and develop best‑in‑class ADCs. \nWhether you are an expert or beginner in the field\, join one of our three content tracks spanning early discovery through manufacturing scale‑up to get up to speed with the latest developments. \nOne Pass\, Three Events: Part of the World Targeted Therapeutics Summit in South Korea organized by Hanson Wade\, this is your opportunity to converge with peers working on targeted protein degradation (TPDs)\, Bispecifics\, and T-cell engagers\, who aim to turn South Korea into the next major global hub for biopharma innovation in targeted therapeutics. \nTo know more visit: https://ter.li/qznxdj
URL:https://www.pharmajournalist.com/event/5th-world-adc-summit-south-korea/
LOCATION:COEX Magok Lewest\, 143 Magokjungang-ro\, Gangseo-gu\, Seoul\, South Korea
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260609
DTEND;VALUE=DATE:20260612
DTSTAMP:20260514T232719
CREATED:20260224T135246Z
LAST-MODIFIED:20260224T135246Z
UID:42990-1780963200-1781222399@www.pharmajournalist.com
SUMMARY:World TPD & Induced Proximity Summit South Korea
DESCRIPTION:The World TPD & Induced Proximity Summit South Korea is the first and only Asian industry event dedicated exclusively to advancing targeted protein degradation (TPD) and induced proximity–based therapeutics. \nAs the global TPD field enters a pivotal era\, with the first PROTAC approval on the horizon and multiple candidates progressing through clinical trials\, South Korea has emerged as a major innovation hub\, fuelled by rapid investment\, strategic partnerships\, and an expanding biotech ecosystem. \nDesigned as an end‑to‑end forum for degraders\, molecular glues\, and degrader antibody conjugates (DACs)\, the summit brings together international opinion leaders and Korean pioneers to address discovery challenges\, translational strategy\, clinical development\, and emerging platform technologies. Deep‑dive sessions explore novel E3 ligases\, AI‑enabled discovery workflows\, proteomics‑driven target identification\, PK/PD optimization\, and case studies showcasing first‑in‑human PROTAC and DAC programs. \nOne Pass\, Three Events: Part of the World Targeted Therapeutics Summit in South Korea organized by Hanson Wade\, this is your opportunity to converge with peers working on antibody-drug conjugates (ADCs)\, Bispecifics\, and T-cell engagers\, who aim to turn South Korea into the next major global hub for biopharma innovation in targeted therapeutics. \nTo know more visit: https://ter.li/tslwfl
URL:https://www.pharmajournalist.com/event/world-tpd-induced-proximity-summit-south-korea/
LOCATION:COEX Magok Lewest\, 143 Magokjungang-ro\, Gangseo-gu\, Seoul\, South Korea
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260609
DTEND;VALUE=DATE:20260612
DTSTAMP:20260514T232719
CREATED:20260224T135629Z
LAST-MODIFIED:20260224T135659Z
UID:42993-1780963200-1781222399@www.pharmajournalist.com
SUMMARY:World Bispecific & T-Cell Engager Summit South Korea
DESCRIPTION:The World Bispecific & T‑Cell Engager Summit South Korea is Asia’s first and only industry‑dedicated forum focused on advancing bispecific antibodies and T‑cell engagers (TCEs)\, modalities that are redefining the therapeutic landscape for solid tumors and immune‑driven diseases. Propelled by landmark regulatory approvals such as tarlatamab and ivonescimab\, bispecifics and TCEs have captured global interest for their ability to address previously unmet medical needs. \nThis inaugural summit brings together international experts and regional leaders for deep‑dive sessions on advanced engineering\, co-stimulation strategies\, antibody masking\, conditional activation\, and the design of trispecific and tetraspecific formats. The agenda also explores bispecific ADCs (bsADCs)\, novel target selection\, TCE expansion into autoimmune disease\, translational biology\, and early clinical readouts shaping development priorities. \nAs South Korea positions itself as a rising global powerhouse in targeted therapeutics\, this summit provides a vital forum for advancing first‑in‑class bispecific and TCE‑based therapies with the potential to transform patient outcomes worldwide. \nOne Pass\, Three Events: Part of the World Targeted Therapeutics Summit in South Korea organized by Hanson Wade\, this is your opportunity to converge with peers working on antibody-drug conjugates (ADCs)\, Bispecifics\, and T-cell engagers\, who aim to turn South Korea into the next major global hub for biopharma innovation in targeted therapeutics. \nTo know more visit: https://ter.li/bw174h
URL:https://www.pharmajournalist.com/event/world-bispecific-t-cell-engager-summit-south-korea/
LOCATION:COEX Magok Lewest\, 143 Magokjungang-ro\, Gangseo-gu\, Seoul\, South Korea
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR